<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR807.html">Part 807
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  807.34  Summary of requirements for owners or operators granted a
                            </h3>
                            <p class="depth1"><em>(a)</em> For initial registration and listing, owners or operators who have been granted a waiver from electronic filing using the procedures set forth in Sec.  807.21(b) must send a letter containing all of the registration and listing information described in Sec. Sec.  807.22, 807.25, (and Sec.  807.26 when such information is requested by FDA), at the times described in Sec.  807.22, to: The Office of Compliance, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 3521, Silver Spring, MD 20993-0002.</p><p class="depth1"><em>(b)</em> As specified in Sec.  807.22(b)(1) and (b)(3), all owners or operators shall update their establishment registration and device listings annually during the period beginning on October 1 and ending on December 31 of each fiscal year.</p><p class="depth1"><em>(c)</em> Failure to submit any of the required information on time, as specified in Sec.  807.22(a) and (b), will put the establishment in a ``failed to register'' or ``failed to list'' status as applicable.</p><p class="depth2">The establishment will not be considered active and the establishment registration and device listing information may not appear on the FDA Web site until the required information is submitted to and processed by FDA.
[77 FR 45943, Aug. 2, 2012]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
